In Rats, Low-Dose THC Felt Rewarding Through CB1 Receptors. Higher Doses Felt Aversive Through CB2.

Using electrical brain stimulation in rats, researchers mapped out how THC affects the brain's reward system at different doses. The result was a clean biphasic pattern: low doses of THC mildly enhanced brain-stimulation reward, while higher doses inhibited it — meaning higher doses made the stimulation less rewarding, not more.

The mechanism split neatly by receptor type. When researchers blocked CB1 receptors, the low-dose reward enhancement disappeared. When they blocked CB2 receptors, the high-dose reward suppression disappeared. Selective CB1 agonists confirmed the reward effect; selective CB2 agonists confirmed the aversive effect.

This provides a biological explanation for why cannabis can feel pleasant at one dose and deeply unpleasant at another — and why inexperienced users who consume too much often have negative experiences rather than simply "more" of the positive experience.

This study provides a mechanistic explanation for something cannabis users know intuitively: there's a sweet spot, and going past it doesn't make things better. The finding that CB1 and CB2 receptors produce opposing effects on reward explains the biphasic dose-response that shows up across cannabis research — in cognition, anxiety, nausea, and now reward.

It also has implications for addiction science. If the rewarding effects are CB1-mediated and self-limiting because CB2 kicks in at higher doses, cannabis may have a built-in ceiling on its rewarding properties. This could partly explain why cannabis has a lower addiction liability than drugs that produce dose-dependent reward without an opposing mechanism.